Literature DB >> 29856540

Under-utilized opportunities to optimize medication management in long-term treatment of schizophrenia.

Matti Isohanni1, Jouko Miettunen1,2, Erika Jääskeläinen1,2,3, Jani Moilanen1, Anja Hulkko1,2, Sanna Huhtaniska1,2.   

Abstract

Entities:  

Year:  2018        PMID： 29856540      PMCID： PMC5980385          DOI： 10.1002/wps.20523

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  7 in total

1.  Use of psychiatric medications in schizophrenia and other psychoses in a general population sample.

Authors:  Salla Nykänen; Virpi Puska; Jussi-Pekka Tolonen; Henri Salo; Matti Isohanni; Hannu Koponen; Sami Pirkola; Matti Penttilä; Marianne Haapea; Jani Moilanen; Jouko Miettunen; Erika Jääskeläinen
Journal:  Psychiatry Res       Date:  2015-11-10       Impact factor: 3.222

2.  Prescriber fidelity to a medication management evidence-based practice in the treatment of schizophrenia.

Authors:  Patricia B Howard; Peggy El-Mallakh; Alexander L Miller; Mary Kay Rayens; Gary R Bond; Karen Henderson; Andrew T Cooley
Journal:  Psychiatr Serv       Date:  2009-07       Impact factor: 3.084

Review 3.  Long-term antipsychotic use and brain changes in schizophrenia - a systematic review and meta-analysis.

Authors:  Sanna Huhtaniska; Erika Jääskeläinen; Noora Hirvonen; Jukka Remes; Graham K Murray; Juha Veijola; Matti Isohanni; Jouko Miettunen
Journal:  Hum Psychopharmacol       Date:  2017-03       Impact factor: 1.672

4.  Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication - a 10-year follow-up of the Northern Finland 1966 Birth Cohort study.

Authors:  J Moilanen; M Haapea; J Miettunen; E Jääskeläinen; J Veijola; M Isohanni; H Koponen
Journal:  Eur Psychiatry       Date:  2011-09-14       Impact factor: 5.361

Review 5.  Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic Review.

Authors:  Saínza García; Mónica Martínez-Cengotitabengoa; Saioa López-Zurbano; Iñaki Zorrilla; Purificación López; Eduard Vieta; Ana González-Pinto
Journal:  J Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.153

6.  Lifetime use of antipsychotic medication and its relation to change of verbal learning and memory in midlife schizophrenia - An observational 9-year follow-up study.

Authors:  Anja P Husa; Irina Rannikko; Jani Moilanen; Marianne Haapea; Graham K Murray; Jennifer Barnett; Peter B Jones; Matti Isohanni; Hannu Koponen; Jouko Miettunen; Erika Jääskeläinen
Journal:  Schizophr Res       Date:  2014-07-15       Impact factor: 4.939

7.  Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication.

Authors:  Juha Veijola; Joyce Y Guo; Jani S Moilanen; Erika Jääskeläinen; Jouko Miettunen; Merja Kyllönen; Marianne Haapea; Sanna Huhtaniska; Antti Alaräisänen; Pirjo Mäki; Vesa Kiviniemi; Juha Nikkinen; Tuomo Starck; Jukka J Remes; Päivikki Tanskanen; Osmo Tervonen; Alle-Meije Wink; Angie Kehagia; John Suckling; Hiroyuki Kobayashi; Jennifer H Barnett; Anna Barnes; Hannu J Koponen; Peter B Jones; Matti Isohanni; Graham K Murray
Journal:  PLoS One       Date:  2014-07-18       Impact factor: 3.240
  7 in total
  3 in total

Review 1.  Achieving the Lowest Effective Antipsychotic Dose for Patients with Remitted Psychosis: A Proposed Guided Dose-Reduction Algorithm.

Authors:  Chen-Chung Liu; Hiroyoshi Takeuchi
Journal:  CNS Drugs       Date:  2020-02       Impact factor: 5.749

2.  Trends in the incidence and DALYs of schizophrenia at the global, regional and national levels: results from the Global Burden of Disease Study 2017.

Authors:  Hairong He; Qingqing Liu; Ning Li; Liyang Guo; Fengjie Gao; Ling Bai; Fan Gao; Jun Lyu
Journal:  Epidemiol Psychiatr Sci       Date:  2020-01-13       Impact factor: 6.892

3.  Discontinuing Antipsychotic Medication After Remission from First-Episode Psychosis: A Survey of Psychiatrists' Attitudes in Taiwan.

Authors:  Ko Yen; Chen-Chung Liu; Yi-Ting Lin; Yi-Ling Chien; Ming H Hsieh; Chih-Min Liu; Tzung-Jeng Hwang; Wei-Hsiang Liao; Hai-Gwo Hwu
Journal:  Neuropsychiatr Dis Treat       Date:  2022-03-01       Impact factor: 2.570
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.